Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The analysis found low doses were as effective as full doses for preventing recurrent VTEs, but low-dose DOAC therapy reduced the risks of major and clinically relevant non-major bleeding events compared with full-dose therapy, with no significant differences between apixaban and rivaroxaban
Important Disclaimer
Heat is used to eliminate microbes and other contaminants from final product
Patients with liver disease frequently take lactulose, rifaximin, beta-blockers (for portal hypertension prophylaxis), diuretics, and sometimes direct-acting antivirals for hepatitis C
Instead, most people may only experience chronic fatigue or frequent headaches from B12 deficiency
US$ 22.41
US$ 26.94
US$ 21.63
US$ 28.33
US$ 24.08
US$ 28.65
US$ 20.92
US$ 27.41
US$ 29.44
US$ 27.05
